Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Fda crawled time : 13:30 save search
ViiV Healthcare announces U.S. FDA approval of Dovato (dolutegravir/lamivudine) for adolescents living with HIV
Published: 2024-04-08 (Crawled : 13:30) - biospace.com/
PFE A | $25.69 -0.85% 0.1% 29M
|
Health Technology
|
| O: -0.39%
H: 0.0%
C: 0.0%
fda approval for hiv living
FDA Greenlights New Antibiotic for SAB, Pneumonia
Published: 2024-04-05 (Crawled : 13:30) - biospace.com/
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: -1.77%
H: 0.0%
C: -1.81%
PRGO A | $29.96 -0.56% 0.0% 1.4M
|
Health Technology
|
| O: -0.22%
H: 0.8%
C: 0.06%
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: -1.84%
H: 0.0%
C: 0.0%
ABT | $109.21 0.29% 0.34% 7.3M
|
Health Technology
|
| O: -0.37%
H: 1.42%
C: 1.37%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -3.44%
H: 0.0%
C: 0.0%
fda for
FDA Approves Vanda Schizophrenia Drug for Bipolar I Disorder
Published: 2024-04-03 (Crawled : 13:30) - biospace.com/
PRGO A | $29.96 -0.56% 0.0% 1.4M
|
Health Technology
|
| O: -0.29%
H: 1.34%
C: -0.64%
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
ABT | $109.21 0.29% 0.34% 7.3M
|
Health Technology
|
| O: 0.11%
H: 0.37%
C: -0.77%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: 0.0%
fda drug schizophrenia
FDA Approves New Treatments for Two Rare Diseases
Published: 2024-03-27 (Crawled : 13:30) - biospace.com/
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
PRGO A | $29.96 -0.56% 0.0% 1.4M
|
Health Technology
|
| O: 0.84%
H: 1.48%
C: 1.29%
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
ABT | $109.21 0.29% 0.34% 7.3M
|
Health Technology
|
| O: 1.48%
H: 0.0%
C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: 0.0%
fda rare
FDA Approves Takeda’s Iclusig for Type of Leukemia, Idorsia’s Hypertension Drug
Published: 2024-03-21 (Crawled : 13:30) - biospace.com/
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: 0.14%
H: 0.24%
C: 0.24%
PRGO A | $29.96 -0.56% 0.0% 1.4M
|
Health Technology
|
| O: 0.0%
H: 1.6%
C: 0.89%
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: 0.0%
ABT | $109.21 0.29% 0.34% 7.3M
|
Health Technology
|
| O: -0.56%
H: 0.0%
C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
fda drug iclusig hypertension
FDA Adcomm to Tackle Complexity of CAR-T for Multiple Myeloma
Published: 2024-03-15 (Crawled : 13:30) - biospace.com/
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
fda car-t
Lantheus Announces the FDA Approval of DEFINITY® (Perflutren Lipid Microsphere) for Pediatric Patients
Published: 2024-03-04 (Crawled : 13:30) - globenewswire.com
LNTH | $61.76 2.51% 2.44% 570K
|
Health Technology
|
| O: 0.56%
H: 1.88%
C: 0.55%
definity fda approval
J&J Wins Full FDA Approval for Rybrevant, Chemo Combo in NSCLC
Published: 2024-03-04 (Crawled : 13:30) - biospace.com/
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
fda approval
Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBC
Published: 2024-02-29 (Crawled : 13:30) - globenewswire.com
ICPT | $19.0 -0.05% 4M
|
Health Technology
| Email alert
Add to watchlist
ocaliva fda drug treatment application
CytoDyn Announces FDA Has Lifted Clinical Hold
Published: 2024-02-29 (Crawled : 13:30) - globenewswire.com
CYDY | $0.145 0.06% 4.7M
|
Manufacturing
|
| O: 18.53%
H: 35.79%
C: 35.53%
fda lifted
Intelligent Bio Solutions Partners with Cliantha Research to Conduct Clinical Study as Part of FDA 510(k) Pathway
Published: 2024-02-28 (Crawled : 13:30) - globenewswire.com
INBS | $2.91 -10.74% -12.03% 80K
|
Manufacturing
|
| O: 0.82%
H: 3.91%
C: -2.44%
fda research solutions study
Capricor Therapeutics Announces Upcoming Type-B Meeting with the FDA to Discuss Commercial Manufacturing Planning with an Aim to Expedite BLA Pathway for CAP-1002 in Duchenne Muscular Dystrophy
Published: 2024-02-27 (Crawled : 13:30) - globenewswire.com
CAPR | $5.945 1.45% 1.43% 280K
|
Health Technology
|
| O: 2.53%
H: 13.6%
C: 6.9%
cap-1002 fda meeting commercial therapeutics duchenne
Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve
Published: 2024-02-02 (Crawled : 13:30) - biospace.com/
EW M | $90.05 0.95% 0.0% 2.6M
|
Health Technology
|
| O: 1.64%
H: 8.09%
C: 7.61%
fda first approval system therapy
SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application
Published: 2024-01-30 (Crawled : 13:30) - globenewswire.com
SIBN 4 | $15.33 0.39% 0.39% 430K
|
Health Technology
|
| O: 0.92%
H: 0.0%
C: -2.22%
fda granite clearance implant application
Immix Biopharma Statement On January 2024 FDA Labeling Change Notification For Approved CAR-T Products
Published: 2024-01-24 (Crawled : 13:30) - globenewswire.com
IMMX | $2.55 -4.14% -4.31% 240K
|
|
| O: -1.91%
H: 14.97%
C: 1.52%
fda change approved biopharma car-t
Cybin Announces FDA Clearance to Initiate a Phase 2a Study of CYB004 in Generalized Anxiety Disorder
Published: 2024-01-23 (Crawled : 13:30) - biospace.com/
CYBN | $0.3796 3.72% -2.03% 3.7M
|
n/a
|
| O: 0.0%
H: 2.37%
C: 0.34%
cyb004 fda clearance study
Scholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat Obesity
Published: 2024-01-23 (Crawled : 13:30) - biospace.com/
SRRK A | $14.0 5.03% 4.79% 390K
|
Health Technology
|
| O: 1.1%
H: 1.48%
C: -5.33%
fda obesity treat clearance application trial rock
AngioDynamics Announces FDA 510(k) Clearance of Auryon XL Radial Access Catheter to Treat Peripheral Arterial Disease
Published: 2024-01-23 (Crawled : 13:30) - biospace.com/
ANGO | $6.51 3.17% 3.07% 510K
|
Health Technology
|
| O: 1.66%
H: 0.33%
C: -2.28%
fda disease treat clearance
J&J Secures Full FDA Approval for Bladder Cancer Drug Balversa
Published: 2024-01-22 (Crawled : 13:30) - biospace.com/
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: 0.0%
fda drug approval bladder cancer balversa
United Health Products Reports on FDA Application Status
Published: 2024-01-19 (Crawled : 13:30) - globenewswire.com
UEEC | $0.2086 4.97% 120K
|
Manufacturing
|
| O: 9.61%
H: 3.6%
C: -7.96%
fda health application
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.